Deborah J. Wexler MD, MSc
Associate Professor of Medicine, Harvard Medical School; Chief, Diabetes Unit, Massachusetts General Hospital, Boston, MassachusettsDr. Deborah J. Wexler's research focuses on clinical effectiveness in type 2 diabetes. In addition, she is on the Editorial Board of Diabetes Care, and is a reviewer for multiple journals.
Disclosures
Dr. Wexler reports serving on Data Monitoring Committees for trials of oral semaglutide sponsored by Novo Nordisk.
Recent Contributions to PracticeUpdate:
- After Intensive Education, Insulin Pump Slightly Better Than Multiple Daily Injections in Type 1 Diabetes
- Diabetic Retinopathy: A Position Statement by the ADA
- ADA Updates for Standards of Care
- 2016 Top Stories in Diabetes: The EMPA-REG RENAL OUTCOMES Trial
- Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes
- Magnitude of Weight Loss and Changes in Physical Fitness Linked With Long-Term Cardiovascular Disease Outcomes in Overweight Diabetics
- Mindful Self-Compassion Intervention Improves Depression, Distress, and HbA1c in People With Diabetes
- Effect of a Paleolithic Diet on Liver Fat
- 2015 Top Stories in Diabetes: Sugar-Sweetened Beverages, Obesity, and Type 2 Diabetes
- Shifting Sands: Preventing CVD in Type 2 Diabetes